Infectious Diseases News and Research

RSS

European researchers define research priorities in biogerontology

The quality of the medical care for geriatric patients is a major investment for society and must imperatively be a research priority in Europe. This is why 50 European researchers, met on May 17 - 19 in Brussels, to define the research priorities in the field of biogerontology for the next 10 to 15 years.

21 May 2010

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Sorrento Therapeutics, Inc. today announced that it has received an Advanced Technology Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus infections, including methicillin-resistant S. aureus, by disrupting quorum sensing, a bacterial communication process essential to virulence.

21 May 2010

Clinical Infectious Diseases journal examines new scientific advances to curb HIV, TB epidemics

As US policymakers consider scaling back on its historic initiative to fight AIDS around the world and downsizing goals to combat tuberculosis, next-generation treatment and prevention strategies to significantly reduce the spread of HIV/AIDS and tuberculosis are now imminent. New science can dramatically change the trajectory of both deadly epidemics, according to a special new issue of the journal Clinical Infectious Diseases.

21 May 2010

MSCRF awards grants to 42 projects under Maryland Stem Cell Research Act of 2006

The Maryland Stem Cell Research Commission has completed its evaluation of the 141 applications in response to its three official Requests for Applications during the FY 2010 funding cycle. The board of directors of the Maryland Technology Development Corporation reviewed the Commission's recommendations and approved 42 projects totaling $11.7 million in funding through the Maryland Stem Cell Research Fund under the Maryland Stem Cell Research Act of 2006.

21 May 2010

Data from Phase 3 clinical trials of PROVENGE in advanced prostate cancer to be presented at ASCO 2010

Dendreon Corporation today announced the upcoming presentation of data from integrated analyses of three Phase 3 PROVENGE (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in advanced prostate cancer, to be presented at the annual meeting of the American Society of Clinical Oncology in Chicago on Monday, June 7 at 8:00 a.m. CT.

21 May 2010

WHA addresses counterfeit medicines

Discussions about combatting counterfeit medicines continued at the 63rd World Health Assembly (WHA) in Geneva on Wednesday, Agence France-Press reports

21 May 2010

Saint Louis University conducts research to find safe, effective vaccination for dengue

Sponsored by the National Institutes of Health, Saint Louis University's Center for Vaccine Development is conducting research of an investigational vaccine designed to prevent people from contracting dengue, a potentially lethal virus that has rapidly spread around the world.

20 May 2010

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).

20 May 2010

Kansas State University researcher awarded NIH grant to study antibiotic-resistant bacteria

Antibiotic-resistant bacteria are becoming a growing problem around the world, and are a particular worry in hospital-acquired infections.

20 May 2010

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.

20 May 2010

University of Sydney hosts emerging infectious diseases and biosecurity conference

The latest research to combat emerging infectious diseases threatening Australia is being presented at the Sydney Institute of Emerging Infectious Diseases and Biosecurity Conference at the University of Sydney today.

19 May 2010

Study results may help researchers determine genetic abnormalities that cause lung disease to develop

Patients who encounter serious lung diseases in middle age, despite an absence of family history or other predisposing factors, may still have their genes to blame, according to a new study conducted by researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

19 May 2010

i3 completes acquisition of ChinaGate

i3, a global life sciences services company and subsidiary of Ingenix, has acquired ChinaGate, a contract research organization that provides product-development regulatory services for pharmaceutical, medical device and biotechnology companies looking to enter and access the Chinese market.

19 May 2010

Experts accelerate discovery and development of new TB drugs: Lancet article

According to a paper published today in the Lancet, there is unprecedented progress in the development of the global tuberculosis drug pipeline with 10 drug candidates currently in clinical development. The paper was written by a team of renowned international experts led by Zhenkun Ma, Ph.D., Chief Scientific Officer for the TB Alliance, a not-for-profit organization accelerating the discovery and development of new TB drugs.

19 May 2010

Low blood phosphorus levels associated with high death rates in African AIDS patients: Research

Low blood phosphorus levels are associated with high death rates in the initial weeks of antiretroviral therapy (ART) in AIDS patients in sub-Saharan Africa, according to new research conducted by University of Alabama at Birmingham researchers at the UAB-affiliated Centre for Infectious Disease Research in Zambia.

19 May 2010

Statue commemorating 30th anniversary of the eradication of smallpox unveiled

A statue commemorating the 30th anniversary of the eradication of smallpox is being unveiled today in front of the World Health Organization headquarters by the Director-General of the World Health Organization, Dr Margaret Chan.

18 May 2010

VBI researchers establish new tree of life for gamma-proteobacteria

A new "tree of life" has been constructed by researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech for the gamma-proteobacteria, a large group of medically and scientifically important bacteria that includes Escherichia coli, Salmonella typhimurium, and other disease-causing organisms.

18 May 2010

Helmholtz Centre for Infection Research receives "Grand Challenges Explorations" grant

The Helmholtz Centre for Infection Research (HZI) has received a grant through the current round of the funding programme "Grand Challenges Explorations" of the Bill & Melinda Gates Foundation. The programme is supporting a global health project for development of nanoparticles that release the vaccine active ingredients through the skin upon contact with perspiration.

18 May 2010

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.

18 May 2010

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2010.

18 May 2010

Infectious Diseases News and Research

European researchers define research priorities in biogerontology

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Clinical Infectious Diseases journal examines new scientific advances to curb HIV, TB epidemics

MSCRF awards grants to 42 projects under Maryland Stem Cell Research Act of 2006

Data from Phase 3 clinical trials of PROVENGE in advanced prostate cancer to be presented at ASCO 2010

WHA addresses counterfeit medicines

Saint Louis University conducts research to find safe, effective vaccination for dengue

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Kansas State University researcher awarded NIH grant to study antibiotic-resistant bacteria

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

University of Sydney hosts emerging infectious diseases and biosecurity conference

Study results may help researchers determine genetic abnormalities that cause lung disease to develop

i3 completes acquisition of ChinaGate

Experts accelerate discovery and development of new TB drugs: Lancet article

Low blood phosphorus levels associated with high death rates in African AIDS patients: Research

Statue commemorating 30th anniversary of the eradication of smallpox unveiled

VBI researchers establish new tree of life for gamma-proteobacteria

Helmholtz Centre for Infection Research receives "Grand Challenges Explorations" grant

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

eBook: Advancing infectious disease vaccine development eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News